WALKER MARLAN D (General Counsel) sold 23.3% of their position (19.05K shares) of THERAPEUTICSMD, INC. on the open market
Open‑market sale worth $43.7K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 12/7/2023ACC: 0001209191-23-057725
Officer· General Counsel
Since Aug 2020
-19.05K
Net shares
Net seller
$43.7K
Total sold
2
Open market trades
0B · 2S
4
Total transactions
70K acquired · 89.05K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
+70K
Price / share
—
Trade value
—
% of position
602.7%
12/5/2023
11.62K→81.61K
Common Stock
Direct
Shares
−14.50K
Price / share
$2.31
Trade value
$33.50K
% of position
17.8%
12/6/2023
81.61K→67.11K
Common Stock
Direct
Shares
−4.55K
Price / share
$2.24
Trade value
$10.19K
% of position
6.8%
12/7/2023
67.11K→62.56K
Total
Net shares
+50.95K
Net value
-$43.68K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/5/2023 | M · Option Exercise | +70K | — | — | 602.7% | 11.62K | 81.61K |
| Common Stock Direct | 12/6/2023 | S · Sale | −14.50K | $2.31 | $33.50K | 17.8% | 81.61K | 67.11K |
| Common Stock Direct | 12/7/2023 | S · Sale | −4.55K | $2.24 | $10.19K | 6.8% | 67.11K | 62.56K |
| Total | +50.95K | -$43.68K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
70K shares
Shares
−70K
Strike price
0.00
Held after
0.00
Exercisable
—
12/5/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock70K shares | 12/5/2023 | M · Option Exercise | −70K | 0.00 | — | 0.00 |